Edition:
United Kingdom

Cytori Therapeutics Inc ‍announces new investigator initiated U.S. clinical trial for hip osteonecrosis​


Monday, 13 Nov 2017 

Nov 13 (Reuters) - Cytori Therapeutics Inc :Cytori Therapeutics Inc - ‍announced a new investigator initiated U.S. clinical trial for hip osteonecrosis​. 

Company Quote

0.2889
0.0095 +3.40%
24 May 2019